Navigation Links
Singapore research team identifies new drug target in deadly form of leukemia
Date:6/3/2013

SINGAPORE A research team led by the Duke-NUS Graduate Medical School (Duke-NUS) in Singapore has identified ways to inhibit the function of a key protein linked to stem cell-like behavior in terminal-stage chronic myeloid leukemia (CML), making it possible to develop drugs that may extend the survival of these patients.

The study, published in the prestigious international journal Proceedings of the National Academy of Sciences, is the result of a long-standing collaboration between Duke-NUS, the Experimental Therapeutics Centre at the Agency for Science, Technology and Research (A*STAR), and the Singapore General Hospital that is focused on developing effective therapies in CML.

CML is a blood cancer that has seen tremendous improvement in treatment outcomes following the introduction of tyrosine kinase inhibitor (TKI) drugs that specifically target the BCR-ABL fusion gene, a genetic abnormality that is characteristic of CML. However, when CML progresses to its terminal stage, known as the blast crisis phase, TKI drugs become ineffective and patients with blast crisis CML rapidly succumb to the disease.

"TKI therapy is highly effective in chronic phase CML, and enables most patients to survive many years. In contrast, patients with blast crisis CML usually succumb to their disease within one year, with most patients dying because they develop drug resistance to TKI therapy," said principal investigator Ong Sin Tiong, associate professor and head of the Laboratory of Hematologic Malignancies in the Cancer and Stem Cell Biology Program at Duke-NUS.

A subset of cells associated with blast crisis CML exhibit characteristics of self-renewing stem cells, suggesting that targeting this particularly malignant and drug-resistant population would be effective in treating blast crisis CML. The team therefore searched for novel targets that will specifically eliminate these cancer stem cells.

Through their efforts, the
'/>"/>

Contact: Juliana Chan
editor@asianscientist.com
65-829-93719
Duke University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. First in the world - Singapore scientists discover genes responsible for cornea blindness
2. National Heart Centre Singapore develops worlds first human heart cell model
3. Singapore scientists find genes associated with glaucoma, a major cause of eye blindness
4. NUS launches new book on Singapores rainforests and new free digital nature archive
5. Made-in-Singapore H5N1 diagnostic kit -- detects all known strains of H5N1 virus with a single test
6. Researchers develop a faster method to identify Salmonella strains
7. Researchers document acceleration of ocean denitrification during deglaciation
8. Researchers design sensitive new microphone modeled on fly ear
9. Researchers help threatened wheat crops in Asia, Africa
10. Roy J. Carver Charitable Trust funds new research focus at Institute for Genomic Biology
11. U of A medical researchers ID genetic marker for sporadic breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2014)... Dr. Debra Auguste, associate professor, biomedical engineering, in ... College of New York, have identified a molecule ... of the most aggressive forms of breast cancer. ... high mortality rate owing to aggressive proliferation and ... However, Professor Auguste,s team, discovered the overexpression of ...
(Date:11/6/2014)... A groundbreaking paper from a team of Florida State ... how plants could adapt to and survive environmental swings ... in the latest issue of the journal The ... complex of DNA and proteins) is organized in a ... some genes are turned on and others are turned ...
(Date:11/6/2014)... 6, 2014 - Insilico Medicine, Inc, a Baltimore-based ... age related diseases announced a research collaboration with ... Champions Oncology, Inc (OTC: CSBR). , "There are ... medicine, but Champions Oncology,s TumorGraft technology is unique ... chemotherapy regimen experimentally generating vast amounts of valuable ...
Breaking Biology News(10 mins):Maize analysis yields whole new world of genetic science 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2
... important for the survival of many types of cells ... cells that connect the cerebral cortex with the spinal ... amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). ... investigators from Massachusetts General Hospital (MGH) and the Harvard ...
... during the earliest phases of infection appears to depend ... called HLA Class I that have been inherited, as ... molecules display to the T lymphocytes that usually destroy ... issue of PLOS Medicine, researchers from the Partners AIDS ...
... packages for scientists eager to find natural substances to ... that is smaller than the proverbial gnat's eyelash. , ... technology, or NMR, scientists have unlocked secrets hidden in ... common two-stripe walking sticks, which are relatively harmless, plant-eating ...
Cached Biology News:Growth factor stimulates rapid extension of key motor neurons in brain 2Early-stage immune system control of HIV may depend on inherited factors 2Early-stage immune system control of HIV may depend on inherited factors 3One-of-a-kind imaging probe reveals secrets useful for drug discovery 2One-of-a-kind imaging probe reveals secrets useful for drug discovery 3
(Date:11/26/2014)... , Nov. 26, 2014 The ... results from a survey of European physicians at ... on Innovation and Biological Therapies" at the Spanish ... event, hosted by EuropaBio and the Spanish Bioindustry ... of Health, physicians from Spanish oncology and rheumatology ...
(Date:11/26/2014)... Charlotte, NC (PRWEB) November 25, 2014 ... High Intensity Focused Ultrasound (HIFU) devices, recently participated ... “ Small Renal Mass 360° .” Key opinion ... and therapeutic advances related to small renal masses ... learn about different ablative technologies in hands-on labs. ...
(Date:11/26/2014)... Miles Holder, formerly of Micron Research ... Products team as Sales/Marketing Manager. Mr. Holder has over ... for the graphite industry. , “We are thrilled to ... Dave Trinkley, VP of Market and Product Development for ... in the graphite industry, along with his proven track ...
(Date:11/26/2014)... 25, 2014 Bio-Techne Corporation (NASDAQ: ... Robert Gavin to serve in a newly created ... Division.  Mr. Gavin will be responsible for managing the ... the ProteinSimple business acquired in July 2014 and the ... Jose, California -based ProteinSimple develops and commercializes proprietary ...
Breaking Biology Technology:ASBM Presents European Physicians Survey at Spanish Ministry of Health 2SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 2SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 3Miles Holder Joins Graphel Corporation as Sales/Marketing Manager 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 3
... , , SADDLE RIVER, N.J., July ... provider of sales and marketing support to U.S. pharmaceutical companies, ... results on Wednesday, August 5, 2009 after the market close. ... conference call beginning at 4:30 p.m. Eastern time on August 5, ...
... , , BRISBANE, Calif., July 29 ... it will release second quarter 2009 financial results on Thursday, August ... call and webcast will be hosted by InterMune at 4:30 p.m. ... access the live teleconference, dial 888-799-0528 (U.S.) or 973-200-3372 (international), conference ...
... , , , ... (Nasdaq: OSTE ), a leader in the emerging ... in a July 24, 2009 letter to the Company, the ... establishing restrictions on the importation and distribution of tissue products ...
Cached Biology Technology:PDI, Inc. to Hold Second Quarter 2009 Financial Results Conference Call on Wednesday, August 5, 2009 2InterMune to Release Second Quarter Financial Results on August 6 2Osteotech Resumes Shipments of Bulgarian Tissue 2Osteotech Resumes Shipments of Bulgarian Tissue 3
Automated centrifuge for the processing of microplates and tubes; can be integrated into automated process using inexpensive robotics due to its unique sample handling platform....
OptiBuffer is a fully optimised medium, designed for,the electroporation of eukaryotic cells. OptiBuffer,improves both transfection efficiencies and survival,rates over PBS or other standard culture...
...
... are cytopathic effect inhibition assays, also known as ... tissue culture supernatents; serum from PK studies and ... is defined as the quantity of interferon required ... viral infection by 50%. All standards ...
Biology Products: